主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ACRV
#3449
Acrivon Therapeutics, Inc. Common Stock
1.5
1
-17.03%
版块:
基础:
利润货币:
日范围
年范围
日变化
-17.03%
每月变动
-23.74%
6个月变化
+11.03%
年变化
-71.51%
前一天收盘价
1.8
2
Open
1.5
1
Bid
Ask
Low
1.5
1
High
1.5
1
交易量
10
市场
股票
医疗保健
ACRV
Open full chart
Financials
Overview
声明
Statistics
Dividends
Quarterly
Annual
Value
2022
2023
2024
TTM
Key stats
Total common shares outstanding
21.92 M
22.64 M
31.35 M
—
Valuation ratios
Enterprise value
224.1 M
77.4 M
148.92 M
190.66 M
Price to earnings ratio
-1.53
-1.83
-2.53
-4.89
Price to sales ratio
88.81
825.46
2 034.27
—
Price to cash flow ratio
1.58
2.59
3.1
5.83
Price to book ratio
0.28
0.91
1.15
1.42
Enterprise value to EBITDA ratio
—
—
—
—
Profitability ratios
Return on assets %
0.17
0.44
0.41
0.49
Return on equity %
0.18
0.5
0.46
0.54
Return on invested capital %
321.19
1 024.9
2 395.3
—
Gross margin %
100
100
100
—
Operating margin %
6 081.38
50.08 K
89.2 K
—
EBITDA margin %
—
—
—
—
Net margin %
5 803.91
45.07 K
80.56 K
—
Liquidity ratios
Quick ratio
—
—
—
—
Current ratio
20.27
9.75
10.55
40.78
Inventory turnover
—
—
—
—
Asset turnover
0
0
0
—
Solvency ratios
Debt to assets ratio
—
—
—
—
Debt to equity ratio
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
Per share metrics
Operating cash flow per share
7.31
1.93
1.94
1.77
EBIT per share
—
—
—
—
EBITDA per share
—
—
—
—
Total debt per share
—
—
—
—
Cash per share
30.99
5.77
5.31
16.14
Net current asset value per share
32.05
5.87
5.37
16.3
Tangible book value per share
41.36
5.49
5.23
16.47
Working capital per share
30.47
5.27
4.87
14.7
Book value per share
41.36
5.49
5.23
16.47
新闻
Acrivon将在ESGO大会上展示ACR-368子宫内膜癌数据
Acrivon to present ACR-368 endometrial cancer data at ESGO congress
Sunday’s Insider Activity: Top Executives Make Strategic Moves
Acrivon Therapeutics首席执行官Blume-Jensen购入价值8.2万美元股票
Acrivon Therapeutics CEO Blume-Jensen buys $82k in shares
Acrivon Therapeutics首席运营官Devroe购入价值1.7万美元股份
Acrivon Therapeutics COO Devroe buys $17k in shares
派博桑德勒上调Acrivon Therapeutics目标价至8美元,看好癌症数据
Piper Sandler raises Acrivon Therapeutics stock price target to $8 on positive cancer data
Acrivon Therapeutics股价因癌症试验结果喜忧参半而暴跌
Acrivon Therapeutics stock plunges after mixed cancer trial results
Why Is Acrivon Therapeutics Stock Falling Today? - Acrivon Therapeutics (NASDAQ:ACRV)